Patents by Inventor Donna Ann Santillan

Donna Ann Santillan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC STRATEGIES FOR THE TREATMENT OF PREECLAMPSIA
    Publication number: 20180228806
    Abstract: Compositions and methods for treating preeclampsia in a subject in need thereof are disclosed.
    Type: Application
    Filed: February 27, 2018
    Publication date: August 16, 2018
    Inventors: Justin L. Grobe, Mark K. Santillan, Donna Ann Santillan
  • Therapeutic strategies for the treatment of preeclampsia
    Patent number: 9937182
    Abstract: Compositions and methods for treating preeclampsia in a subject in need thereof are disclosed.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: April 10, 2018
    Inventors: Justin L. Grobe, Mark K. Santillan, Donna Ann Santillan
  • EARLY PREDICTION OF PREECLAMPSIA
    Publication number: 20170315130
    Abstract: The invention relates to methods and kits for diagnosing or predicting the likelihood of occurrence of preeclampsia in a subject with no history of the disease.
    Type: Application
    Filed: May 1, 2017
    Publication date: November 2, 2017
    Inventors: Justin L. Grobe, Mark K. Santillan, Donna Ann Santillan
  • THERAPEUTIC STRATEGIES FOR THE TREATMENT OF PREECLAMPSIA
    Publication number: 20150374698
    Abstract: Compositions and methods for treating preeclampsia in a subject in need thereof are disclosed.
    Type: Application
    Filed: February 10, 2014
    Publication date: December 31, 2015
    Inventors: Justin L. GROBE, Mark K. SANTILLAN, Donna Ann SANTILLAN
  • ANTI-MULLERIAN HORMONE CHANGES IN PREGNANCY AND PREDICTION OF ADVERSE PREGNANCY OUTCOMES AND GENDER
    Publication number: 20140057295
    Abstract: The present invention provides for methods for evaluating the risk of an adverse pregnancy outcome in a subject and methods for treating subjects evaluated as being high risk. In some aspects, the present invention provides a method of evaluating the risk of an adverse pregnancy outcome in a subject, where if the subject does have an abnormal level of AMH as compared to a predetermined normal level the subject is more likely to have an adverse pregnancy outcome, and if the subject does not have an abnormal level of AMH the subject is less likely to have an adverse pregnancy outcome. In other aspects, the present invention provides a method of determining the gender of a fetus comprising obtaining information regarding the level of AMH in a sample from a pregnant subject.
    Type: Application
    Filed: February 28, 2012
    Publication date: February 27, 2014
    Inventors: Barbara J. Stegmann, Donna Ann Santillan, Mark K. Santillan